Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |
mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |